Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with high morbidity and mortality. The cellular source of the fibrotic process is currently under debate with one suggested mechanism being epithelial-to-mesenchymal transition (EMT) in the alveolar region. In this study, we show that airway epithelium overlying fibroblastic foci in IPF contains a layer of p63-positive basal cells while lacking ciliated and goblet cells. This basal epithelium shows increased expression of CK14, Vimentin and N-cadherin while retaining E-cadherin. The underlying fibroblastic foci shows both E-and N-cadherin-positive cells. To determine if p63-positive basal cells were able to undergo EMT in culture, we treated VA10, a p63-positive basal cell line, with the serum replacement UltroserG. A sub-population of treated cells acquired a mesenchymal phenotype, including an E-to N-cadherin switch. After isolation, these cells portrayed a phenotype presenting major hallmarks of EMT (loss of epithelial markers, gain of mesenchymal markers, increased migration and anchorage-independent growth). This phenotypic switch was prevented in p63 knockdown (KD) cells. In conclusion, we show that airway epithelium overlying fibroblastic foci in IPF lacks its characteristic functional identity, shows increased reactivity of basal cells and acquisition of a partial EMT phenotype. This study suggests that some p63-positive basal cells are prone to phenotypic changes and could act as EMT progenitors in IPF.
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with high morbidity and mortality. The cellular source of the fibrotic process is currently under debate with one suggested mechanism being epithelial-to-mesenchymal transition (EMT) in the alveolar region. In this study, we show that airway epithelium overlying fibroblastic foci in IPF contains a layer of p63-positive basal cells while lacking ciliated and goblet cells. This basal epithelium shows increased expression of CK14, Vimentin and N-cadherin while retaining E-cadherin. The underlying fibroblastic foci shows both E-and N-cadherin-positive cells. To determine if p63-positive basal cells were able to undergo EMT in culture, we treated VA10, a p63-positive basal cell line, with the serum replacement UltroserG. A sub-population of treated cells acquired a mesenchymal phenotype, including an E-to N-cadherin switch. After isolation, these cells portrayed a phenotype presenting major hallmarks of EMT (loss of epithelial markers, gain of mesenchymal markers, increased migration and anchorage-independent growth). This phenotypic switch was prevented in p63 knockdown (KD) cells. In conclusion, we show that airway epithelium overlying fibroblastic foci in IPF lacks its characteristic functional identity, shows increased reactivity of basal cells and acquisition of a partial EMT phenotype. This study suggests that some p63-positive basal cells are prone to phenotypic changes and could act as EMT progenitors in IPF. Idiopathic pulmonary fibrosis (IPF) is a severe lung disease characterized by progressive diminution in lung function based on an underlying fibrotic process in the lung parenchyma. 1 The characteristic fibrosis contains the so-called fibroblastic foci found in close proximity to the lung epithelium. Many studies have indicated the importance of the pulmonary epithelial cells as the initial cellular target of injury. [2] [3] [4] Although critical steps in the progressive fibrosis have been delineated, there are still major questions unanswered, especially regarding the interaction between epithelium and fibroblastic foci and cellular origin of the myofibroblasts that dominate in fibrotic foci of IPF. Different cellular sources have been suggested to contribute to the fibroblastic foci in IPF. These include resident fibroblasts/myofibroblasts from the lung, mesenchymal stem cells derived from blood that have taken residence within the lung parenchyma and lung epithelial cells that have undergone epithelial-to-mesenchymal transition (EMT). 5 EMT is a process well known in normal development, wound healing and cancer metastasis. [6] [7] [8] The initiation of EMT is commonly marked by repression of the epithelial cell adhesion molecule E-cadherin and the dissociation of epithelial cells. The epithelial cells lose their distinct marker expression and gain a mesenchymal expression profile and morphology. 9 This expressional switch includes an increase in the expression of various mesenchymal markers, such as Vimentin, N-cadherin and fibronectin. 10 Recently, studies have shown that various microRNAs (miRNAs), predominantly the miR-200 family, have an important role in both EMT and lung fibrosis. 11, 12 The miR-200 family member miR-200c is believed to be pivotal when it comes to the downregulation of E-cadherin, one of the hallmarks of EMT. 13 When this miRNA is downregulated, its target, the transcription factor ZEB1, is free to downregulate E-cadherin expression. 14 To argue against EMT as a driver of fibrosis in IPF, it has been shown that in the bleomycin-induced mouse model of pulmonary fibrosis multiple stromal cell populations contributed to the pulmonary fibrosis without any evidence for EMT. 15 A more recent study suggested pathophysiological differences between human IPF and the bleomycin-induced mouse model and furthermore, suggested that the transcription factor GRHL2 may have a crucial role in epithelial activation in lung fibrosis and perhaps also in epithelial plasticity. 16 Basal cells reside in the airway epithelium from the trachea and, in diminishing numbers, down to the respiratory bronchioles. 17 They are candidate stem cells in the conducting airways, responsible for normal cell replacement and epithelial remodeling upon lung injury. 18 Upon damage in airway epithelium, the basal cells show increased reactivity demonstrated by increased expression of p63, a basal cell restricted transcription factor and its downstream target cytokeratin 14 (CK14). 19, 20 Recent studies have implicated p63 with EMT. Das et al 21 showed that fibrotic lesions in oral submucosa showed marked upregulation of p63 and Oh et al 22 showed that primary human keratinocytes transfected with ΔNp63 underwent EMT when they had depleted their normal proliferative capacity.
Alveolar type II cells have been suspected as the cellular source of IPF through EMT. 2, 4 However, the contribution of basal cells has also been implicated. Chilosi et al 23 showed highly increased numbers of p63-positive cells in bronchioles of IPF lungs, at areas showing both epithelial hyperplasia and squamous metaplasia. Seibold et al 24 found bronchial basal-, ciliated-and goblet cells to populate the characteristic honeycomb cysts in IPF lungs. However, the possible connection between basal cells and the EMT process in IPF still remains an open question. One reason for the lack of current understanding of the cellular origin of IPF is the lack of representing cell culture models to study diseases progression.
We have recently generated a bronchial epithelial cell line referred to as VA10. VA10 has basal cell properties evidenced by p63 and CK14 expression and its ability to generate pseudostratified epithelium in air-liquid interface (ALI) culture. 25 In addition, this cell line forms bronchio-alveolarlike structures in three-dimensional co-culture with endothelial cells. 25, 26 In this study, we focus on the p63-positive lung epithelial basal cell as one potential progenitor cell for the myofibroblast in IPF.
We present data demonstrating that the epithelial cells in airways adjacent to fibroblastic foci show evidence of partial mesenchymal differentiation. Furthermore, using the VA10 in vitro basal cell model, we show that basal cells are able to undergo EMT, evidenced by both expression pattern, as well as cellular phenotypic characterization and that this transition is dependent upon p63 being present in the cells.
MATERIALS AND METHODS Ethics Statement
Lung tissue samples were provided by written informed consent from patients who underwent open lung surgical procedures. This study was approved by the Landspitali Hospital Ethics Committee. Reference number 88374-96345.
Samples of Lung Tissue from Patients with IPF Samples were analyzed from eight patients who underwent open lung biopsy at the Department of Cardiothoracic Surgery at Landspitali University Hospital. In all cases, the surgical biopsy was obtained with video-assisted thoracoscopic surgical approach that has been described elsewhere. 27 These patients fulfilled criteria for having IPF as judged by a multidisciplinary clinical team. Sections that showed clear fibroblastic foci were selected. Control samples were obtained from patients who had undergone lobectomies and were free of pulmonary fibrosis.
Cell Culture
The bronchial epithelial cell line VA10 was previously established at the laboratory. 25 VA10 cells were cultured in LHC-9 medium (Invitrogen, NY, USA) supplemented with 50 IU/ml penicillin and 50 mg/ml streptomycin (Invitrogen). UltroserG-treated VA10 cells were cultured in DMEM/F12 (Invitrogen) supplemented with 2% UltroserG (Pall Biosepra, France) and 50 IU/ml penicillin and 50 mg/ml streptomycin (Invitrogen). 3D cultures were performed as previously described. 26 Production of Lentivirus and Cell Transduction Lentiviral transduction was performed as previously described. 28 In short, plasmids containing scrambled hairpin (pLKO.1 shSCR; Addgene plasmid 17920) 29 or shRNA against p63 (shp63alpha pLKO.1 puro; Addgene plasmid 19120) 30 were used with packaging plasmids (psPAX2 and pMD2.G) (Addgene plasmids 12260 and 12259, respectively) to generate viral titer in HEK-293 T cells using Arrest-in (Open Biosystems). Transduction of VA10 cells was performed using low MOI volume and 8 mg/ml polybrene and positive cells selected with 0.7 μg/ml puromycin.
Cell Sorting VA10 cells were sorted using Magnetic Cell Sorting (MACS, Miltenyi Biotec, Germany). Cells were suspended in MACS buffer (Miltenyi Biotec) and incubated, either with primary microbeads for EpCAM (CD326, Miltenyi Biotec) or unconjugated primary antibody for Thy-1 (clone AS02) for 30 min at 4°C. Unbound beads or antibody were removed by three consecutive washes with MACS buffer. For primary antibodies, a secondary incubation with anti-mouse IgG microbeads (Miltenyi Biotec) was conducted for 30 min at 4°C. After incubation, cells were washed three times with MACS buffer. Cells were then suspended in 1 ml of MACS buffer and either loaded onto manual MACS separation columns (MS or LD columns, Miltenyi Biotec) or run through an autoMACS cells sorter (Miltenyi Biotec).
Migration Assay
A total of 20 000 starved VA10 cells (DMEM only, 24 h) were seeded onto migration filters (8 μm pores, BD Bioscience) in DMEM (Invitrogen) supplemented with 50 IU/ml penicillin and 50 mg/ml streptomycin (Invitrogen). Endothelial growth medium (LONZA) supplemented with 5% FBS (Invitrogen) was then added to the lower well. Cells were allowed to migrate for 24 h. Then fixed for 5 min in 3.5% formaldehyde (Sigma Aldrich) and stained with 0.1% crystal violet for 15 min. Filters were rinsed with PBS and cells on the apical layer of the filter wiped off with a Q-tip. Density of migrated cells was evaluated by dissolving migrated cells in 0.5 ml 10% acetic acid (Sigma Aldrich) and measuring optical density at 590 nm using a spectrometer.
Soft Agar Assay
Plates were coated with 1% soft agar (Sigma Aldrich) diluted in DMEM (Invitrogen) and kept at 4°C for 20 min to allow solidification. A total of 30 000 cells were seeded into 0.5% soft agar preheated to 40°C and placed onto the solidified 1% surface. The plate was incubated at 4°C for 10 min to allow solidification of the upper layer. Cells were then cultured for 20 days. After 20 days, cells were stained with 0.05% crystal violet for 1 h and colonies over 30 μm in size were counted in each well using a phase contrast microscope (Leica). Three representative areas were counted in each well. Each experiment was conducted in triplicate.
RNA Isolation, cDNA Synthesis and qRT-PCR RNA was isolated from VA10 cells using TriReagent solution (Sigma Aldrich). Reverse transcription was carried out using the RevertAid First Strand Synthesis Kit (Fermentas) according to the manufacturer's instructions. For quantification of miR-200c, hsa-miR-200c-3p LNA™ PCR primer set (Exicon, 204482) was used with an 3' non-fluorescent MGB quencher and FAM 5' reporter dye. GAPDH was used as the endogenous reference gene and amplified using commercially available primers (Applied Biosystems, 4326317E). Data were analyzed using 7500 Software v2.0 (Applied Biosystems).
Immunochemistry
Paraffin-embedded tissue samples of control and IPF lung biopsies were obtained from the Department of Pathology, Landspitali University Hospital. The samples were deparaffinized, antigen retrieved by boiling in TE buffer for 20 min (unless stated otherwise) and stained with EnVisionH+ System-HRP kit (Dako) according to the manufacturer's instructions. Primary antibodies (see below) incubated at RT for 30 min. Cell cultures were fixed with 3.5% fomaldehyde for 10 min at RT or with methanol at -20°C. Cultures were then washed two times with PBS and then blocked with 10% FBS in IF buffer (0.2% Triton X-100; 0.1% BSA and 0.05% Tween-20 in PBS). Primary antibodies incubated for 30 min at RT followed by three 10-min washes with PBS. Secondary isotype-specific Alexa Fluor antibody conjugates (Invitrogen) were incubated for 30 min at RT. Nuclei stained for 15 min at RT using TO-PRO-3 (Invitrogen). Samples were embedded in Fluoromount-G (Southern Biotech, Birmingham, AL, USA) and analyzed with confocal microscopy (Zeiss LSM5 Pasqal). Representative confocal images were quantified using CellProfiler. 31 
Western Blot
In all, 5 μg of protein lysate was mixed with 4X NuPage LDS sample buffer (Invitrogen), reduced with mercaptoethanol (Sigma Aldrich) and heated to 75°C for 10 min. Then loaded on 10% SDS Bis-Tris gels (Invitrogen) and run on 180 V for 45 min in 1X NuPage MES running buffer (Invitrogen). Proteins were transferred at 30 V for 1.5 h in 1X NuPage transfer buffer (Invitrogen) containing 10% methanol to a methanol-activated (Sigma Aldrich) PVDF membrane (Millipore). After transfer, membrane was washed in PBS at room temperature for 5 min and then blocked with 5% BSA (Applichem) in TBS+0.1% Tween (Sigma Aldrich) for 1 h. Primary antibodies were incubated overnight at 4°C in 5% BSA in 0.1% TBS+Tween. The next day, the membrane was washed for 3 × 10 min in PBS. Secondary infrared (IR) antibodies (LiCOR) were incubated in 0.1% TBS-Tween +0.02% SDS (Sigma Aldrich) for 1 h at 1:20 000 dilution. Subsequently, the membrane was washed for 3 × 10 min in PBS. Signal detection and analysis were performed using an Oddysey Infrared Image Scanner and the corresponding Image Studio software (LiCOR). 32 is strongly expressed in the bronchial epithelium adjacent to fibroblastic foci ( Figure 1 ). Another basal cell marker, the transcription factor p63, a known regulator of CK14 expression showed increased expression that follows a similar pattern as CK14.
List of antibodies
No expression of CK14 and p63 was found within the fibroblastic foci. Interestingly, the epithelium shows a more stratified squamous phenotype around the foci with CK14 and p63 expression also found in suprabasal cells ( Figure 1 and Supplementary Figure S1 ). We found it to be a general rule of thumb that airway epithelium adjacent to a focus showed this phenotype. E-cadherin was strongly expressed in all epithelial cells, but interestingly, cells within the fibroblastic foci also stained positive, whereas E-cadherin expression in control samples is limited to the epithelium (Figure 1 ). To further analyze whether the epithelial cells had acquired a mesenchymal phenotype, we stained for N-cadherin, a classical marker for EMT. N-cadherin is highly expressed during human lung development but in the normal adult human lung N-cadherin is primarily expressed in mesothelial cells and scattered basal cells in bronchioles. 33 Interestingly, basal cells close to fibroblastic foci showed increased N-cadherin expression compared with control samples. When we stained for the mesenchymal marker Vimentin, strong expression was seen in the stroma, including the sub-epithelial fibroblastic foci. Expression of Vimentin was also highly upregulated in epithelium adjacent to fibroblastic foci.
Phenotypic Plasticity of Bronchial-Derived Basal Epithelial Cells in Culture
Given the mixed mesenchymal and epithelial differentiation pattern in the bronchial epithelium adjacent to fibroblastic foci and the presence of E-cadherin-positive cells within the foci, we wanted to evaluate whether bronchial-derived basal cells could undergo phenotypic changes toward EMT, thus Figure 1 Basal cell reactivity, hyperplasia and upregulation of EMT markers adjacent to fibroblastic foci. Epithelium adjacent to fibroblastic foci shows increased reactivity and mesenchymal phenotype. Sparse staining of CK14 is seen in control samples, whereas CK14 is strongly expressed in epithelium overlying fibroblastic foci. P63, a restricted transcription factor for basal cells is expressed in epithelial cells located both basally and in the top layer indicating formation of metaplasia in IPF samples. E-cadherin is abundant in epithelium both in control and IPF samples. In addition, E-cadherin is present in cells within the foci. N-cadherin is expressed in lower basal epithelial cells in IPF samples whereas control samples are negative. Vimentin is expressed in both epithelium and mesenchyme in IPF samples. Bar 100 μm.
contributing to the fibrotic process of pulmonary fibrosis. We have previously generated a human bronchial-derived basal epithelial cell line (VA10) that is capable of generating a pseudostratified epithelial layer in ALI cultures. 25 In addition, VA10 forms bronchioalveolar-like structures in 3D co-culture with endothelial cells 26 demonstrating the stem cell-like properties of this cell line. To analyze the plasticity of cells with basal cell properties, we tested if VA10 cells could be induced to undergo EMT. In vivo the bronchial basal cell is steadily maintained and, furthermore, gives rise to daughter cells capable of undergoing mucociliary differentiation. This in vivo-like behavior can be mimicked in culture using one of several culture media and the right in vitro conditions. We selected the serum substitute UltroserG (UG) commonly used for ALI culture to facilitate differentiation of basal cells 34, 35 and a known inducer of EMT. 36, 37 In contrast to the cuboidal epithelial phenotype seen in monolayer when cultured in bronchial-defined medium (serum-free LHC-9 medium), a sub-population of VA10 cells in UG supplemented media (2%) showed distinct changes toward a mesenchymal phenotype (Figure 2, top panel) . In UG media, the VA10 cells arrange into two distinct sub-populations, islands of cuboidal epithelial-like cells separated by a zone of elongated fibroblast-like cells (Figure 2 , top right: arrows). Immunophenotypic characterization revealed that the epithelial-like islands displayed an epithelial phenotype, expressing EpCAM, CK14 and E-cadherin. The elongated fibroblast-like cells, however, showed a mesenchymal phenotype as evidenced by reduced expression of EpCAM, CK14 and E-cadherin and acquisition of N-cadherin expression ( Figure 2 , lower two panels: arrows and outline and Supplementary Figure S2) . Interestingly, no phenotypic change is observed when VA10 cells are treated with transforming growth factor beta 1 (TGF-β1), a well-known EMT inducer (data not shown). EpCAM is ubiquitously expressed in bronchial epithelium but its high expression has been linked to stem cell properties in number of epithelial tissues. 38, 39 Furthermore, downregulation of EpCAM is frequently observed in EMT. 40 top panel). The epithelial and mesenchymal phenotype in VA10E and VA10M, respectively, were further evaluated with immunocharacterization (Figures 3b and c) . Western blotting (Figure 3b) showed that untreated VA10 cells (in bronchial medium) and treated VA10 cells (in UG medium) showed strong expression of the epithelial markers E-cadherin and EpCAM. Expression of Vimentin was observed in both cell population but no expression of N-cadherin was seen in VA10E. VA10E cells showed a strict epithelial phenotype, whereas VA10M cells were negative for both E-cadherin and EpCAM but positive for mesenchymal markers (Figure 3b ). These phenotypic differences were further characterized and confirmed by immunofluorescence staining. VA10E cells were strongly positive for CK14, EpCAM and E-cadherin but negative for N-cadherin, Thy-1. Vimentin expression can still be observed in a few cells (Figure 3c, left) . VA10M cells on the other hand had lost their epithelial phenotype except for occasional positive CK14 cells. VA10M were uniformly positive for the mesenchymal markers Thy-1, Vimentin and N-cadherin (Figure 3b, right) . Collectively, we have generated a mesenchymal sub-line from VA10 by exposing the cells to the serum substitute UG. The mesenchymal-like cells referred to as VA10M have undergone phenotypic changes suggestive of EMT.
VA10M Has Acquired a Functional Mesenchymal Phenotype
To further analyze the mesenchymal properties of VA10M, we conducted various functional assays that have been shown to associate with EMT. Migration, a phenotype associated with mesenchymal cells, was tested using a transwell migration assay. Although the VA10 and VA10E cell lines showed similar migratory capabilities, VA10M cells showed almost twofold more migration than the VA10E cells (Figure 4a ). Anchorage-independent growth has also been linked with a mesenchymal phenotype and while both VA10 and VA10E cells show limited anchorage-dependent growth, the VA10M cells had three-to fourfold increased number of colonies compared with VA10E in a soft agar assay (Figure 4b) .
A number of miRNAs, including the mir-200 family, has been shown to be important in the preservation of epithelial integrity. In particular, loss of miR-200c expression has been associated with loss of epithelial integrity and EMT. 14 Although both VA10 and VA10E cells retain their miR-200c expression, its expression is markedly downregulated in VA10M. Also, in accordance to the miR-200c expression, upregulation of the mesenchymal EMT marker fibronectin was clearly detected in VA10M (Figure 4c) . When cultured in a three-dimensional matrigel-based co-culture system with endothelial cells, both treated VA10 and VA10E cells form branching bronchioalveolar-like structures like the original VA10 cell line. 26 Under these conditions, approximately 10% of colonies form large branching structures (Figure 4d, white  bars) . However, when VA10M cells were cultured in the same three-dimensional co-culture system they did not exhibit any branching but instead formed large spindle-like colonies similar to fibroblasts (Figure 4d, black bars) . In all co-culture conditions, approximately 90% of colonies were small with no distinct morphology (Figure 4d, gray bars) . These various functional assays show that although the VA10E sub-line retains the phenotype exhibited by its mother cell line (VA10), the VA10M cells have gained a markedly different phenotype, with clear mesenchymal properties. Interestingly, VA10M can be reverted back to the original phenotype by culturing the cells on LHC-9 medium (Supplementary Figure S3) . In summary, we have shown that the p63-positive basal cell line VA10 is able, under specific conditions, to undergo EMT, both with regard to protein expression and cellular phenotype.
KD of p63 Abrogates UG-Stimulated EMT Capacity of VA10
To evaluate whether the expression of p63 is necessary for the mesenchymal transformation of VA10 cells, we performed a lentiviral-based stable KD with p63 and control scrambled shRNA in VA10 (VA10 p63KD and VA10 SCR , respectively). This resulted in a significant decrease in p63 protein levels (Supplementary Figure S4) . When cultured in UG media, no spindle-like phenotype was observed in VA10 p63KD , compared with VA10 SCR ( Figure 5 ). Immunostaining revealed that the VA10 p63KD cells showed no upregulation of N-cadherin or Thy-1, whereas retaining E-cadherin expression, in contrast to VA10 SCR ( Figure 5 ). VA10 SCR showed more Vimentin expression in E-cadherin-negative cells, whereas Vimentin was exclusively co-expressed with E-cadherin in KD cells, indicating no sub-population distinction.
DISCUSSION
In this study, we have shown that basal epithelial cells overlying fibroblastic foci in IPF patient samples acquire increased reactivity as measured by p63 and CK14 expression and acquisition of a partial mesenchymal phenotype as measured by N-cadherin and Vimentin expression. Although we cannot claim that basal cells are the cellular source of fibroblasts within the foci, there is no doubt that the overlying epithelium, in particular the basal cells, acquire mesenchymal traits that may be either the consequence of signals derived from the foci or signify that the epithelium is directly contributing to their formation by undergoing EMT. Furthermore, our in vitro studies show that the p63-positive basal cell line VA10 is able to undergo a mesenchymal transition as evidenced by induction of EMT upon culture in UG containing medium.
In the IPF samples, we see that the epithelium overlying the fibroblastic foci is rich in p63-positive cells that have not only a basal but also a suprabasal pattern and show a mixed E-and N-cadherin expression along with both CK14 and Vimentin expression (Figure 1 ). This pattern is indicative of a partial EMT in the epithelial cells. Underlying this abnormal epithelium, there are abundant mesenchymal cells forming the fibroblastic foci but we can also see occasional E-cadherin-positive cells within the foci. This is an interesting pattern with abnormal p63-positive epithelial cells with signs of partial EMT overlying the mesenchymal-rich fibroblastic foci. This pattern thus raises the question whether the epithelium, specifically the p63-positive cells could contribute to the fibroblastic foci through EMT. Double positive CK14/ p63-positive basal cells are rare in the airway and such cells have been associated with injury or wound-healing responses. 42 Interestingly, Oh et al 22 have shown that primary human keratinocytes transfected with ΔNp63 underwent EMT when they had depleted their normal proliferative capacity. Thus, injury-response CK14/p63-positive cells in the epithelium overlying the fibroblastic foci could be a cellular source for EMT.
Up to 20% of IPF cases have been suggested to be familial, often referred to as familial interstitial pneumonia (FIP). 43 Conventional genetic approaches have identified four genes that are involved in FIP. These four genes encode proteins in two separate functional families: surfactant proteins, surfactant protein C (SFTPC) 44 and surfactant protein A2 (SFTPA2), 45 and components of the telomerase complex, telomerase reverse transcriptase (TERT) and the RNA component of telomerase (TERC). 46, 47 More recently, Schwartz and colleagues have, through several publications, linked a common single-nucleotide polymorphism in the promoter region of the mucin gene MUC5B to idiopathic interstitial pneumonias, including IPF. [48] [49] [50] The mutations in the surfactant family proteins, SFTPC and SFTPA2, both expressed exclusively by type II alveolar epithelial cells (AECs) in the lungs, suggest that AEC dysfunction is a prominent feature of IPF. Furthermore, accumulating evidence supports endoplasmic reticulum (ER) stress with consequent apoptosis as a prominent feature in IPF. Compared with COPD and normal lungs, protein levels of ER stress mediators, such as ATF-6, ATF-4 and the apoptosisinductor C/EBPzeta, were elevated in AECs of IPF lungs. 51 How ER stress with subsequent epithelial injury leads to a fibrotic response in the adjacent mesenchymal compartment is still intensely debated. The two major hypotheses are that epithelial cells adjacent to the injured area undergo EMT or that the injury leads to proliferation of the local mesenchymal cells, such as fibroblasts or myofibroblasts. 43 Although the surfactant type mutations have a described mechanism of epithelial injury through ER stress, the mechanism by which telomerase dysfunction (TERT and TERC mutations) leads to IPF is less understood. It is thought that epithelial cell dysfunction may be mediated by epithelial cell senescence and impaired response to epithelial injury, as a consequence of telomere dysfunction. 52 Although most investigators agree that the epithelial compartment is where the initial injury occurs in IPF, there is much less known about the following events. As stated above, the main debate focuses on the origin of the cellular components of the fibrotic response. The progressive nature of the fibrotic scarring is what drives the destructive nature of IPF. The data collected with mouse models of surfactant mutants suggest that fibrosis in the commonly used bleomycin mouse model worsens in the background of ER stress. 53 In the same bleomycin model with surfactant (SFTPC) mutated mice, the data also support the notion that ER stress can contribute to EMT in vivo. 54 Overexpression of mutant SFTPC in lung epithelial cell lines largely recapitulated the ER stress-induced EMT. 55 To argue against EMT as a driver of fibrosis, it has been shown as previously discussed that in the bleomcyininduced model multiple stromal cell populations contributed to the pulmonary fibrosis without any evidence for EMT. 15 Another important unsolved issue is the epithelial cell of origin contributing to epithelial injury and EMT. The surfactant mutants would strongly suggest the AEC-type II cells, given their almost exclusive expression of surfactant proteins. This is also supported by the fact that the initial and main fibrotic changes in IPF are located distally in the airways. The possible contribution of the MUC5B promoter region polymorphism to IPF pathogenesis raises the question whether epithelia in upper airways may also contribute to IPF. In the normal lung, MUC5B is expressed in sub-mucosal cells of the upper airways, whereas goblet cells express MUC5B under stress conditions. 56 In addition, TGF-β1-induced EMT is a well-documented process in A549, an alveolar type II cell line. 57 Interestingly, TGF-β1 does not induce EMT in VA10 nor another bronchial-derived epithelial cell line, Calu-3. 57 This indicates that the mechanism of EMT could be different in bronchial-derived cells compared with alveolar cells.
We have previously shown that VA10 cells can capture phenotypic architecture of upper and lower airways depending cell culture conditions. When cultured in ALI-conditions, VA10 cells can generate pseudostratified epithelium mimicking trachea and larger bronchi and bronchioles. In this model, VA10 generates differentiated ciliated cells as well as goblet cells upon induction. 28 In addition, we showed when VA10 is embedded into three-dimensional basement membrane matrix in co-culture with endothelial cells, we see increase in branching structures capturing bronchioalveolar phenotype. 26 Given this plasticity of the basal cell line VA10 and the expression pattern found in IPF lungs, it can be hypothesized that the basal cell could contribute to the fibrotic process in IPF through EMT.
